Breast cancer Flashcards

1
Q

Describe breast cancer screening in the UK.

A
  • All women 47-73y offered screening
  • screening with 2-view mammography at a screening centre
  • normal screen:
    (i) 3-year recall
  • abnormal screen:
    (i) immediate recall for further investigation
    (ii) either all clear, early recall in 6months or 1y, or diagnosis of breast cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What screening, if any, is available for high-risk women <50y?

A
  1. high-risk women aged 40-49: offered annual 2-view mammography
  2. women known to have a genetic mutation:
    - annual MRI from 20y if TP53 mutation
    - annual MRI from 30y if BRCA1/2 mutation
  3. MRI surveillance offered for:
    - women 30-39y with 10-year risk >8%
    - women 40-49y with 10-year risk >20%
    - at-risk women 40-49 with a dense pattern on mammography
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the pros and cons of breast cancer screening?

A

Pros:

  • earlier diagnosis
  • improved prognosis and lower mortality
  • less radical and invasive treatment needed
  • reassurance for those with -ve results

Cons:

  • discomfort and inconvenience of screening
  • radiation risks of screening (v small)
  • reassurance to those who have false -ve results
  • reassurance to those who develop an interval cancer and possibly present later due to false sense of security
  • anxiety + adverse effects of further investigations
  • over diagnosis of minor abnormalities that would never develop into breast cancer
  • earlier knowledge of disease and over treatment for who those, despite early diagnosis, ahve unchanged prognosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the risk factors for breast cancer?

A
  1. Personal characteristics:
    - increasing age (~81% of breast cancers occur in women >50y)
    - taller women have icnreased risk
    - women with denser breast have 2-6x increased risk
  2. Lifestyle factors:
    - obesity icnreases risk post-menopause
    - 30% reduction in risk if exercising regularly
    - high fat diet
    - alcohol increases the risk by 7%/unit consumed/day
  3. Reproductive history:
    - early menarche or late menopause increases the risk
    - pregnancy: increased parity reduced risk; first childbirth at late age increases risk
    - breastfeeding reduces the relative risk by 4.3% for each year of breastfeeding
    - COCP: slight increased risk; excess risk disappears 10ys after stopping
    - HRT: increases risk and reduces sensitivity of mammography
  4. Other PMH:
    - past history of breast disease: ductal or lobular carcinoma in situ, papilloma with fibrovascular core
    - ionising radiation exposure increases risk
  5. Family history:
    - One 1st degree relative with breast cancer (95% of women who develop breast cancer have no FHx)
    - Several family members with early onset breast cancer (BRCA1/2 genes account for 2-5% of all breast cancers)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How does receptor status of a breast cancer impact prognosis?

A

oestrogen -ve tumours have poorest prognosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How can breast cancer present?

A
  1. Breast lump (90%)
  2. Breast pain (21% present with painfullumo; breast pain alone <1%)
  3. Nipple skin change (10%) → any red, scaly lesions or eczema around the nipple Paget’s disease of the breast (intraepidermal, intraductal cancer)
  4. Family history (6%)
  5. Skin contour change (5%)
  6. Nipple discharge (3%)
  7. Rarely presents with distant metastases (e.g. bone pain)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How are potential breast cancers investigated?

A
  1. Specialist investigations:
    - mammography
    - USS
    - ± fine needle aspiration (looks at cells) or core biopsy (looks at tissue)
  2. if diagnosis confirmed, fiurther investigations include:
    - tumour markers
    - CT/MRI
    - liver USS
    - bone scan (to evaluate spread)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the features of breast cancer in situ? What is the TNM equivalent of in situ?

A

Features:
- non-invasive

TNM:
Tis N0 M0

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the features of stage 1 breast cancer? What is the TNM equivalent of stage 1?

A

Features:

  • ≤2cm diameter
  • no lymph nodes affected
  • no spread beyond breast

TNM:
- T1 N0 M0

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the features of stage 2 breast cancer? What is the TNM equivalent of stage 2?

A

Features:

  • 2-5cm diameter
  • ± lymph nodes in axilla involved
  • no spread beyond axilla

TNM:

  • T0-2 N1 M0
  • T2/3 N0 M0
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the features of stage 3 breast cancer? What is the TNM equivalent of stage 3?

A

Features:

  • > 5cm diameter
  • lymph nodes in axilla involved
  • no spread beyond axilla

TNM:

  • T0-2 N2 M0
  • T3 N1/2 M0
  • T4 any N M0
  • Any T N3 M0
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the features of stage 4 breast cancer? What is the TNM equivalent of stage 4?

A

Features:

  • any sized tumour
  • lymph nodes in axilla may be affected
  • distant metastases

TNM:
- Any T/N M1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the management options fo rbreast cancer?

A
  1. surgery (lumpectomy ± axillary clearance, mastectomy)
  2. endocrine therapy
  3. radiotherapy
  4. chemotherapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What adjuvant endocrine therapies are available in the treatment of breast cancer?

A
  1. Tamoxifen
  2. Aromatase inhibitors
  3. Trastuzumab
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the MOA of Tamoxifen? What type of breast cancer is it used for? How long should it be taken for?

A
  1. Oestrogen antagonist
  2. Used un oestrogen receptor +ve tumours (60% of breast cancers) in any age
  3. continue for ≥5 years
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the MOA of aromatase inhibitors? What type of breast cancer is it used for? How long should it be taken for?

A

Aromatase inhibitors = anastrozole, letrozole, exemestane

  1. Blocks synthesis of oestrogen
  2. more effective in post-menopausal with hormone-sensitive early breast cancer (when compared to tamoxifen)
    - 1st choice in post menopausal women wpith advanved cancer
  3. continue for ≥5 years
17
Q

What is the MOA of Trastuzumab? What type of breast cancer is it used for? How long should it be taken for?

A
  1. Monoclonal antibody directed against HER2 receptor (20% of breast cancers)
    - affects divisions and growth of breast cancer cells
  2. HER2 receptor +ve tumours
    - early, hgih risk of recurrence, and advanced HER2+ve cancers
  3. Administered via IV every 3 weeks for 1 year